Heeney
Celine Marguerite Simone Heeney, Southampton GB
Patent application number | Description | Published |
---|---|---|
20080275026 | Benzamide derivatives as oxytocin agonists and vasopressin antagonists - Novel compounds according to general formula 1, wherein G | 11-06-2008 |
20110312941 | 1,4-DISUBSTITUTED PIPERIDINES AS VASOPRESSIN RECEPTOR VIA ANTAGONISTS - The present invention provides compounds of formula (1) compositions comprising such compounds; the use of such compounds in therapy (such as in the treatment of dysmenorrhoea); and methods of treating patients with such compounds; wherein A and G are as defined herein. | 12-22-2011 |
Celine Marguerite Simone Heeney, Portswood GB
Patent application number | Description | Published |
---|---|---|
20090029965 | Vasopressin V1a Antagonists - The present invention concerns compounds inter alia according to general formula 1 | 01-29-2009 |
20120101082 | VASOPRESSIN V1A ANTAGONISTS - The present invention concerns compounds inter alia according to general formula 1a. Compounds according to the invention are vasopressin V | 04-26-2012 |
Jonathan Heeney, Voorburn NL
Patent application number | Description | Published |
---|---|---|
20160002320 | THERAPEUTIC AGENT - Anti-HLA and other antibodies are present in goat serum after injection of HIV antigenic material, and form the basis for a most surprisingly effective treatment of HIV, multiple sclerosis and other conditions. | 01-07-2016 |
Jonathan Heeney, Rijswijk NL
Patent application number | Description | Published |
---|---|---|
20100047276 | Recombinant Vectors Based On the Modified Vaccinia Ankara Virus (MVA) as Preventive and Therapeutic Vaccines Against Aids - Recombinant vectors which are based on the Modified Ankara Virus (MVA) as preventive and therapeutic vaccines against AIDS. The recombinant viruses object of the invention contain sequences which are inserted at the same MVA insertion site and which enable the simultaneous expression of various antigens, a HIV-1 Env protein consisting of a gp120 protein lacking sequences corresponding to protein gp 41 and a chimeric fusion protein of Gag, Pol and Nef. Said viruses are stable and can trigger immune responses against a large variety of antigens. Those viruses having a chimeric protein that derives from sequences of HIV-1 are suitable for the preparation of preventative or therapeutic vaccines against AIDS, particularly for use as vaccination protocols comprising various doses and different vectors, as demonstrated by assays performed using other vectors from the invention, having the same genome organization, but a chimeric protein that derives from sequences of pathogenic SHIV | 02-25-2010 |
Jonathan Heeney, Voorburg NL
Patent application number | Description | Published |
---|---|---|
20100291102 | Therapeutic Agent - Anti-HLA and other antibodies are present in goat serum after injection of HIV antigenic material, and form the basis for a most surprisingly effective treatment of HIV, multiple sclerosis and other conditions. | 11-18-2010 |
20110086046 | Treatment of MS with goat serum - A serum composition from a goat immunised with HIV contains anti-HLA antibody and is suited for palliative improvement of the condition of an animal. | 04-14-2011 |
20120100156 | Therapeutic Agent - Anti-HLA and other antibodies are present in goat serum after injection of HIV antigenic material, and form the basis for a most surprisingly effective treatment of HIV, multiple sclerosis and other conditions. | 04-26-2012 |
20130195890 | TREATMENT OF MS WITH GOAT SERUM - A serum composition from a goat immunised with HIV contains anti-HLA antibody and is suited for palliative improvement of the condition of an animal. | 08-01-2013 |
20130230600 | THERAPEUTIC AGENT - Anti-HLA and other antibodies are present in goat serum after injection of HIV antigenic material, and form the basis for a most surprisingly effective treatment of HIV, multiple sclerosis and other conditions. | 09-05-2013 |
Luke Heeney, Bedford GB
Patent application number | Description | Published |
---|---|---|
20110195172 | BEVERAGES COMPRISING POTASSIUM - The present invention relates to food products comprising potassium salts, and has as an object to provide a food product enriched in potassium which helps in reduction of blood pressure, however without the bitter taste associated with increased potassium levels. The invention provides a beverage comprising potassium at a total concentration between 3 and 15 gram potassium per liter, and locust bean gum. | 08-11-2011 |
Martin Heeney, Surrey GB
Patent application number | Description | Published |
---|---|---|
20120112178 | OPTOELECTRONIC DEVICES - An optoelectronic device comprises electon donor D and acceptor A semiconducting species and an intervening co-oligomeric or copolymeric species provided to alter the energy transfer characteristics of excitons to or from the interface between the said electron acceptor and donor species. The intervening species may be of the form A | 05-10-2012 |
Martin Heeney, Southhampton GB
Patent application number | Description | Published |
---|---|---|
20090314997 | SUBSTITUTED BENZODITHIOPHENES AND BENZODISELENOPHENES - The invention relates to novel substituted benzodithiophenes and benzodiselenophenes, their use especially as semiconductors or charge transport materials in optical, electro-optical or electronic devices and to such devices comprising the novel materials. | 12-24-2009 |